BlackRock Health Financial Statements From 2010 to 2024
| BME Etf | USD 38.66 0.31 0.81% |
Gross Profit 7.7 M | Profit Margin 6.8394 | Market Capitalization 528 M | Enterprise Value Revenue 9.5919 | Revenue 8 M |
Check BlackRock Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BlackRock Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . BlackRock financial statements analysis is a perfect complement when working with BlackRock Health Valuation or Volatility modules.
BlackRock |
BlackRock Health Sciences ETF Beta Analysis
BlackRock Health's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current BlackRock Health Beta | 0.67 |
Most of BlackRock Health's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BlackRock Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, BlackRock Health Sciences has a Beta of 0.672. This is much higher than that of the Capital Markets family and significantly higher than that of the Financials category. The beta for all United States etfs is notably lower than that of the firm.
BlackRock Health Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BlackRock Health's current stock value. Our valuation model uses many indicators to compare BlackRock Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BlackRock Health competition to find correlations between indicators driving BlackRock Health's intrinsic value. More Info.BlackRock Health Sciences is second largest ETF in price to earning as compared to similar ETFs. It is fifth largest ETF in price to book as compared to similar ETFs fabricating about 0.13 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for BlackRock Health Sciences is roughly 7.81 . Comparative valuation analysis is a catch-all technique that is used if you cannot value BlackRock Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About BlackRock Health Financial Statements
BlackRock Health stakeholders use historical fundamental indicators, such as BlackRock Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although BlackRock Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in BlackRock Health's assets and liabilities are reflected in the revenues and expenses on BlackRock Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BlackRock Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. Blackrock Health is traded on New York Stock Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.